Track topics on Twitter Track topics that are important to you
Drug discovery software company Schrödinger raised $232 million in its IPO, which closed Monday. The company’s stock was trading at $27.22 on Tuesday.
Original Article: Schrodinger raises $232M in IPONEXT ARTICLE
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...